user

Empress Therapeutics

Biotechnology Research

View the employees at

Empress Therapeutics
  • image
    Nathaniel Mahieu Metabolomics, Proteomics, Data | Biological Chemistry Ph.D.
    • Cambridge, Massachusetts, United States
    • Rising Star
    View Details
  • image
    Boris Hayete SVP, Head of Computational Discovery at Empress Therapeutics
    • Needham
    • Rising Star
    View Details
  • image
    Andrew King Associate Director, Synthetic Biology at Empress Therapeutics
    • Cambridge, Massachusetts, United States
    • Rising Star
    View Details
  • image
    Nathaniel Mahieu Metabolomics, Proteomics, Data | Biological Chemistry Ph.D.
    • Cambridge, Massachusetts, United States
    • Rising Star
    View Details
  • image
    Boris Hayete SVP, Head of Computational Discovery at Empress Therapeutics
    • Needham, Massachusetts, United States
    • Top 5%
    View Details

Overview

Founded by Flagship Pioneering in 2020, Empress Therapeutics generates good medicines, fast, by starting with chemistry inside the human body. The Empress Chemilogics(TM) platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body to create first- or best-in-class oral medicines for a broad range of diseases quickly, predictably, and cost-effectively.

We’ve covered every

Location Around You

Nestled in a vibrant locale, our location provides a dynamic backdrop, fostering creativity and productivity.

  • Massachusetts Institute of Technology

    Massachusetts Institute of Technology, Harold Place, The Port, Cambridgeport, Cambridge, Middlesex County, Massachusetts, 02238, United States

    Get Direction